Type 1 Diabetes (IMAGE)

La Jolla Institute for Immunology

Type 1 Diabetes

Caption

A promising therapeutic candidate for type 1 diabetes combines anti-IL-21 antibody with the diabetes drug liraglutide.

Credit

La Jolla Institute for Immunology

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.